Fruzsina Mezei | Nursing and Health Professions | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Fruzsina Mezei
Università Cattolica del Sacro Cuore
Fruzsina Mezei
Affiliation Università Cattolica del Sacro Cuore
Country Italy
Scopus ID 57225091697
Documents 8
Citations 65
h-index 3
Google Scholar JlzScJMAAAAJ&hl
Subject Area Nursing and Health Professions
Event International Invention Awards
ORCID 0000-0001-5924-9781

Fruzsina Mezei is a researcher affiliated with Università Cattolica del Sacro Cuore whose scholarly activities contribute to nursing and health professions research through evidence-based investigation and interdisciplinary collaboration. Her published studies demonstrate engagement with healthcare improvement, scientific methodology, and clinical knowledge development. Indexed academic outputs and measurable citation indicators reflect the visibility of her work within international databases, supporting recognition for sustained contributions to healthcare research and innovation.[1]

Abstract

Fruzsina Mezei has established a developing academic profile within nursing and health professions through research emphasizing evidence-based practice, healthcare quality, and interdisciplinary collaboration. Her indexed publications contribute to scientific understanding by addressing clinically relevant questions and supporting informed healthcare decision-making. Bibliometric indicators demonstrate growing scholarly visibility, while citation performance reflects recognition by the wider research community. Through collaboration with healthcare researchers and institutions, her work promotes methodological rigor, knowledge dissemination, and practical application. These characteristics collectively illustrate an active research trajectory appropriate for academic recognition within international innovation and research award programs.[2]

Keywords

Nursing Research, Health Professions, Clinical Research, Evidence-Based Practice, Healthcare Innovation, Scientific Collaboration, Medical Education, Patient Care, Healthcare Quality, Research Impact.

Introduction

Academic research within nursing and health professions plays an essential role in advancing healthcare quality and improving patient outcomes through systematic investigation. Fruzsina Mezei contributes to this objective by participating in scholarly research that supports evidence generation, encourages interdisciplinary cooperation, and strengthens scientific understanding within healthcare environments while maintaining alignment with internationally recognized research standards.[3]

Research Profile

The research profile of Fruzsina Mezei reflects continued scholarly activity documented within Scopus and supported by measurable publication and citation metrics. Her affiliation with Università Cattolica del Sacro Cuore provides an environment encouraging multidisciplinary collaboration, academic excellence, and meaningful healthcare research addressing clinically relevant challenges across nursing and health professions.[1]

Research Contributions

Her scientific contributions emphasize rigorous investigation, collaborative publication, and dissemination of healthcare knowledge through peer-reviewed research. These studies contribute to understanding healthcare practice, clinical outcomes, and evidence-based approaches while supporting future investigations. Such contributions strengthen academic dialogue and encourage continuous improvements within nursing and related healthcare disciplines internationally.[4]

Publications

The documented publication record includes peer-reviewed journal articles indexed within Scopus, demonstrating consistent engagement with healthcare research. These publications collectively represent scientific productivity and collaboration while contributing evidence to professional literature. Their accessibility through international indexing services enhances discoverability, supports citation growth, and promotes broader academic communication across healthcare research communities.[1]

Research Impact

Research impact may be observed through publication visibility, citation performance, and scholarly engagement within international databases. The available bibliometric indicators demonstrate that Fruzsina Mezei’s work has attracted academic attention and contributes to ongoing scientific discussions. Such measurable outcomes indicate meaningful participation in healthcare research while supporting future collaborative opportunities and continued scientific development.[2]

Award Suitability

Considering documented scholarly productivity, international indexing, measurable citation indicators, and contributions to nursing and health professions, Fruzsina Mezei demonstrates characteristics commonly associated with candidates for research recognition. Her sustained academic engagement, commitment to evidence-based investigation, and collaborative scientific output align appropriately with the objectives of the International Invention Awards and similar research excellence programs.[5]

Conclusion

Fruzsina Mezei maintains a growing academic profile supported by indexed publications, scholarly citations, and interdisciplinary healthcare research. Her documented achievements illustrate meaningful scientific participation and demonstrate continued commitment to advancing nursing and health professions through evidence-based inquiry, making her research profile suitable for professional academic recognition and international visibility.[2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Fruzsina Mezei, Author ID 57225091697.
    https://www.scopus.com/pages/authors/57225091697
  2. ORCID. (n.d.). Fruzsina Mezei ORCID Record.
    https://orcid.org/0000-0001-5924-9781
  3. Journal article. (2022.). Digitális egészségügyi technológiák értékelése – Diabétesz applikációk Németországban.
    https://doi.org/10.53020/IME-2022-207
  4. Journal article. (2021.). Countrywide survey on utilization of medical devices by GPs in Hungary: advantages of the cluster-practice model.
    https://doi.org/10.1017/s1463423621000372
  5. International Invention Awards. (2026.). Official Award Website.
    https://inventionawards.org/

Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Published on by Invention Awards

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Leticia Szadai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Leticia Szadai
Lund University, Sweden

Leticia Szadai
Affiliation Lund University
Country Sweden
Google Scholar ID CNcrXOIAAAAJ
Documents 27
Citations 175
h-index 7
Subject Area Medicine and Dentistry
Event International Invention Awards

The Best Researcher Award recognizes researchers whose scholarly activities have contributed to the advancement of knowledge and innovation within their respective disciplines. Leticia Szadai of Lund University has developed a research profile centered on melanoma biology, proteomics, biomarker discovery, and translational cancer research. Her work integrates advanced molecular analysis with clinical applications, supporting improved understanding of melanoma progression, recurrence mechanisms, and therapeutic opportunities. Through collaborative research efforts, she has contributed to the generation of valuable datasets and analytical frameworks relevant to modern oncology research.[1]

Abstract

This article summarizes the academic achievements and research contributions of Leticia Szadai. Her work primarily focuses on melanoma proteomics, molecular pathology, biomarker identification, and translational oncology. Through participation in multidisciplinary investigations, she has contributed to the development of proteomic resources and analytical methods that support precision medicine approaches in cancer research.[2]

Keywords

Melanoma, Proteomics, Molecular Pathology, Biomarkers, Translational Medicine, Cancer Research, Precision Oncology, Tumor Biology.

Introduction

Advances in cancer research increasingly depend on interdisciplinary methodologies that connect molecular science with clinical practice. Leticia Szadai has contributed to this field through studies examining melanoma biology and the molecular factors associated with disease progression and recurrence. Her research reflects contemporary efforts to improve diagnostic and prognostic strategies through large-scale proteomic investigation.[3]

Research Profile

As a researcher affiliated with Lund University, Leticia Szadai has participated in projects involving molecular oncology, clinical proteomics, and translational medicine. Her publication record demonstrates engagement with collaborative international research initiatives focused on melanoma tissue analysis, mitochondrial regulation, immune response mechanisms, and biomarker discovery. These efforts contribute to the broader objective of enhancing evidence-based cancer management.[4]

Research Contributions

  • Contributed to studies establishing comprehensive melanoma proteome atlases.
  • Investigated molecular pathology and protein expression patterns in melanoma.
  • Explored mitochondrial dysfunction and immune response dysregulation associated with melanoma recurrence.
  • Participated in biomarker discovery using archived tumor samples and advanced proteomic technologies.
  • Supported research into kinase signaling pathways and translational applications in oncology.

Publications

  • The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome (2021).
  • The Human Melanoma Proteome Atlas—Defining the Molecular Pathology (2021).
  • Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence (2023).
  • Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out (2021).
  • A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma (2021).

Research Impact

The available citation metrics indicate that Leticia Szadai’s research outputs have attracted scholarly attention within oncology and translational medicine communities. Her involvement in high-impact collaborative studies has supported the development of proteomic resources that facilitate future investigations into melanoma progression, biomarker validation, and personalized therapeutic strategies. These contributions demonstrate measurable academic influence and continuing relevance to cancer research.[5]

Award Suitability

Leticia Szadai’s research portfolio aligns with the objectives of the International Invention Awards and the Best Researcher Award category. Her scholarly contributions reflect innovation in proteomic methodology, translational cancer research, and biomarker development. The combination of publication activity, collaborative leadership, and clinically relevant outcomes supports recognition for contributions to medicine and dentistry-related scientific advancement.[6]

Conclusion

Leticia Szadai has established a research profile characterized by rigorous investigation of melanoma biology and proteomics. Her contributions to translational oncology, biomarker discovery, and molecular pathology have supported scientific understanding of cancer mechanisms and potential clinical applications. These achievements provide a strong foundation for academic recognition through the Best Researcher Award.

References

  1. Elsevier. (n.d.). Google Scholar author details: Leticia Szadai
    https://scholar.google.com/citations?hl=hu&user=CNcrXOIAAAAJ
  2. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.451
  3. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Defining the Molecular Pathology. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.473
  4. Szadai L et al. (2023). Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.1495
  5. Szadai L et al. (2021). Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out. Cancers.
    https://doi.org/10.3390/cancers13236105
  6. Velasquez E et al. (2021). A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.466

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

John Dundon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. John Dundon | Medicine and Dentistry | Research Excellence Award 

Orthopedic Research Institute of New Jersey | United States

Dr. John M. Dundon is a board-certified orthopedic surgeon and clinician–scientist with a distinguished research profile focused on adult reconstruction, total hip and knee arthroplasty, surgical innovation, and value-based orthopedic care. As a Full Partner at Tri-County Orthopedics and previously at the Orthopedic Institute of New Jersey, Dr. Dundon combines high-volume clinical practice with impactful academic research aimed at improving surgical precision, patient outcomes, and healthcare efficiency in joint replacement surgery. A central theme of Dr. Dundon’s research is the optimization of total joint arthroplasty through advanced technologies, including computer-assisted navigation, imageless systems, and smart implants. His work has demonstrated that navigation-assisted techniques significantly improve component positioning accuracy in complex primary and revision total hip arthroplasty, directly contributing to reduced complications, improved biomechanics, and better long-term implant survival. He has also explored objective gait analysis using smart implants, showing how real-time data can guide early postoperative interventions and enhance functional recovery following total knee arthroplasty. Dr. Dundon has made notable contributions to perioperative care pathways and health systems research. His studies on multimodal pain management protocols have shown that opioid use, patient-controlled analgesia, and femoral nerve blocks can be safely reduced or eliminated without compromising patient comfort, aligning surgical practice with modern opioid-sparing strategies. Additionally, his work on bundled payment models and quality metrics has provided evidence that structured care initiatives can significantly improve outcomes while reducing readmissions and healthcare costs. The development of the Readmission Risk Assessment Tool (RRAT) further highlights his commitment to predictive analytics and patient optimization in arthroplasty. His research portfolio also addresses implant biomechanics, tribocorrosion, femoral stem sizing, leg-length discrepancy correction, and postoperative imaging utilization, reflecting a comprehensive approach to both technical and clinical challenges in orthopedic surgery. Dr. Dundon has authored influential review articles and textbook chapters, including contributions to Orthopedic Knowledge Update and The Adult Hip, which serve as key references for practicing surgeons and trainees worldwide. With an extensive record of peer-reviewed publications, national and international presentations, and leadership roles within major orthopedic societies such as the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, Dr. Dundon is widely recognized for bridging evidence-based research and clinical excellence. His research profile reflects sustained innovation, interdisciplinary collaboration, and a clear commitment to advancing the safety, effectiveness, and value of modern joint replacement surgery.

Citation Metrics (Scopus)

1000
600
400
200
50
0

Citations
641

i10index
20

h-index
9

Citations

i10-index

h-index

View Scopus Profile

Featured Publications

Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Dr. Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Dr. Gabriella Teresa Capolupo | Università campus bio medico di Roma | Italy

Gabriella Teresa Capolupo is an accomplished surgeon, researcher, and academic with extensive expertise in general, oncological, and digestive surgery. She has built a distinguished career that integrates advanced clinical practice with dedicated teaching and scientific contributions. As a university lecturer and instructor, she actively contributes to academic programs in General Surgery, Urology, Digestive Surgery, Endocrinology and Metabolic Surgery, Emergency Surgery, and Head and Neck Surgery. Her educational roles include formal teaching, clinical tutoring, multidisciplinary course integration, and participation in advanced training initiatives such as postgraduate master programs and summer schools. She also serves as coordinator of the tutoring activities for the School of Specialization in General Surgery, ensuring high-quality mentorship for surgical trainees and supporting their academic and clinical progression. Her academic profile is further strengthened by appointments to evaluation bodies, including doctoral examination committees in translational medicine and oncology. Clinically, Dr. Capolupo’s work is rooted in continuous service at a major university hospital, where she has operated within colorectal, general, and geriatric surgery units. She performs a broad range of surgical procedures with recognized expertise in abdominal oncological surgery using both laparotomic and laparoscopic approaches. Her responsibilities include acting as first surgeon, surgical assistant, and tutor in the operating room, as well as leading emergency surgical teams. She has held roles with functional leadership responsibilities across both permanent and fixed-term appointments. Her research activity is substantial and internationally recognized, with 2,050 citations, 105 scientific documents, and an h-index of 19, reflecting her influence and scholarly impact in the field of surgical sciences. Dr. Capolupo’s professional trajectory demonstrates a strong and consistent commitment to clinical excellence, scientific advancement, and the training of future medical professionals.

Profiles: Scopus | Orcid

Featured Publications

Schiavone, V., Carannante, F., Melone, G., Miacci, V., Costa, G., Taffon, C., Caricato, M., Capolupo, G. T., & Mascianà, G. (2025). Tailoring the management of colonic lipomas: A 10-year experience of surgical and endoscopic resection. Journal of Personalized Medicine, 15(11), 544. https://doi.org/10.3390/jpm15110544

Schiavone, V., Capolupo, G. T., Mascianà, G., Carannante, F., Costa, G., Miacci, V., & Caricato, M. (2025). Non-operative management (NOM) in rectal cancer: Current evidence and future directions. Encyclopedia, 5(4), 165. https://doi.org/10.3390/encyclopedia5040165

Carannante, F., Capolupo, G. T., Barberio, M., Altamura, A., Miacci, V., Scopigno, M. Z., Circhetta, E., Costa, G., Caricato, M., & Viola, M. G. (2024). Evaluation of short-term effects on colorectal surgery elective patients after implementing a patient blood management program: A multicenter retrospective analysis. Journal of Clinical Medicine, 13(15), 4447. https://doi.org/10.3390/jcm13154447

Feola, A., Minotti, C., Marchetti, D., Caricato, M., Capolupo, G. T., Marsella, L. T., & La Monaca, G. (2021). A five-year survey for plastic surgery malpractice claims in Rome, Italy. Medicina, 57(6), 571. https://doi.org/10.3390/medicina57060571

Mascianà, G., Capolupo, G. T., Carannante, F., & Caricato, M. (2019). An omental mass. Any idea? International Journal of Surgery Case Reports, 57, 161–164. https://doi.org/10.1016/j.ijscr.2019.02.019

Catarci, M., Ruffo, G., Borghi, F., Patriti, A., Delrio, P., Scatizzi, M., Mancini, S., Garulli, G., Carrara, A., Pirozzi, F., et al. (2019). Colorectal surgery in Italy: A snapshot from the iCral study group. Updates in Surgery, 71, 515–524. https://doi.org/10.1007/s13304-018-00612-1

Carannante, F., Mascianà, G., Lauricella, S., Caricato, M., & Capolupo, G. T. (2019). Correction to: Skin bridge loop stoma: Outcome in 45 patients in comparison with stoma made on a plastic rod. International Journal of Colorectal Disease, 34(12), 2195–2197. https://doi.org/10.1007/s00384-019-03451-7

Shibel Ageel | Medicine | Best Researcher Award

Published on by Invention Awards

Dr. Shibel Ageel | Medicine | Best Researcher Award 

Dr. Shibel Ageel | Faculty of Medicine Novi Sad | Croatia

Dr. Shibel Ageel is a dedicated and multilingual medical doctor educated at the Medical Faculty of Novi Sad, University of Novi Sad, graduating in June 2024 as one of the top-ranking students. He has gained broad and diverse clinical experience across Croatia, Serbia, and Tunisia, completing rotations in otorhinolaryngology and head and neck surgery, plastic and reconstructive surgery, general and abdominal surgery, and demonstrating strong technical and diagnostic skills consistently praised by senior surgeons. His passion for surgery, research, and teaching is evident through active participation and poster presentations at numerous medical conferences, including the Osijek Student Congress (OSCON 2020–2024), SaMED 2020 in Sarajevo, and IMSCNS 2019 in Novi Sad. Dr. Ageel has authored and co-authored five peer-reviewed publications including studies and case reports in the MDPI Journal and other indexed medical journals, covering topics such as septoplasty outcomes, fetal tuberous sclerosis, gastric trichobezoars, uterine prolapse, and prurigo diabeticorum. His research bridges surgical innovation and clinical case documentation, contributing valuable insights into ENT and surgical case management. Recognized for his excellence, he received multiple awards including Best Poster Presentation at OSCON 2023, Best Conference Ambassador at OSCON 2024, and a City of Osijek Scholarship for academic distinction. Certified in Basic Life Support (2018) and Advanced Life Support (2024) by the European Resuscitation Council, he combines clinical competence with academic rigor and communication skills. His publications have collectively received growing scholarly recognition with 35 citations in indexed databases and an h-index of 2, reflecting his early yet impactful research trajectory. Driven by curiosity, empathy, and intercultural competence, Dr. Ageel continues to advance in the medical field through clinical excellence, patient-centered care, and research that integrates evidence with global medical collaboration.

Profile: Orcid 

Featured Publications

Tomljenovic, D., Grguric, L., Knežević, M., Svetina, L., Geber, G., Vagic, D., Shibel, A., & Kosec, A. (2025). Comparing nasal patency outcomes in patients undergoing septoplasty with radiofrequency turbinate reduction, turbinectomy, or valvuloplasty: A prospective cohort study. Medicina, 61(9), 1656.

Irineu Loturco | Health Professions | Best Researcher Award

Published on by Invention Awards

Prof Dr. Irineu Loturco | Health Professions | Best Researcher Award

Prof. Dr. Irineu Loturco | Federal University of Sao Paulo | Brazil 

Prof. Dr. Irineu Loturco Filho (born May 22, 1972, Brazil) is a distinguished researcher, educator, and practitioner in sports science, specializing in high-performance training, neuromuscular adaptations, strength, power, and speed development. He holds a degree in Sports from the University of São Paulo (1999), a Professional Master’s in High-Performance Sports from Universidad Autónoma de Madrid (2009), and both a Master’s (2010) and PhD (2014) in High-Performance Sports from Universidad Pablo de Olavide, Spain, where his research focused on the effects of training load sequencing on strength, speed, and muscle power. Loturco currently serves as Director of Sport Science & Research Leader at the Núcleo de Alto Rendimento Esportivo de São Paulo (NAR-SP), coordinating postgraduate programs in training methodology and supervising research on training periodization, performance monitoring, and neuromuscular development. He is also a professor and advisor at the Federal University of São Paulo (UNIFESP) and a visiting professor at the University of South Wales, contributing to both national and international sports science research. Over his career, he has worked with elite athletes and professional teams including Clube Atlético Mineiro, Sociedade Esportiva Palmeiras, and Sport Club Corinthians Paulista, as well as national organizations such as the Brazilian Football Confederation and Brazilian Karate Confederation. His current research investigates strategies to enhance athletic performance, including weighted vest training, seasonal performance variation, and injury prevention. Recognized internationally for his contributions, Loturco has received awards such as the 2019 SCS Investigator Award and honors for his work in adaptive sports and high-performance athlete development, solidifying his position as a leading authority in strength and conditioning science.

Profile: Orcid

Featured Publications

Survey Studies: Connecting Sport Science to Coaching Practice – International Journal of Sports Physiology and Performance

Training at Different Velocity Zones: Does It Really Matter? – International Journal of Sports Physiology and Performance

Neuromuscular and Performance Responses to Resisted Sprint Loads in Elite Female Sprinters

Effects of a Short-Term Ballistic Training Program on Performance and Strength Deficit in Elite Youth Female Soccer Players – Sports,

Effects of Loaded and Unloaded Jumps Used as Priming Activities in Elite Male Rugby Union Players

Archana Ayyar | Reproductive Biology | Best Researcher Award

Published on by Invention Awards

Dr. Archana Ayyar | Reproductive Biology | Best Researcher Award

University Hospitals, United States

Profile

ORCID

🧠 Early Academic Pursuits

Dr. Archana K. Ayyar began her academic journey with distinction, earning dual undergraduate degrees in Psychology (B.S.) and Finance (BBA) from The University of Texas at Austin between 2011 and 2015. During this time, she consistently earned accolades such as University Honors, College Scholar, and Dean’s Honor List recognitions. Her academic excellence led her to the prestigious Texas Tech University Health Science Center in Lubbock, where she pursued her Doctor of Medicine (M.D.) from 2015 to 2019. Her early interest in women’s health and research excellence was evident from her Outstanding Student of the Year (Ob/Gyn) award in 2019.

🩺 Professional Endeavors and Clinical Training

Dr. Ayyar’s medical training includes a Residency in Obstetrics and Gynecology (2019–2023) at Baylor College of Medicine, Houston, TX, followed by her current Fellowship in Reproductive Endocrinology and Infertility (2023–present) at University Hospitals, Case Western Reserve University, Cleveland, Ohio. Her trajectory through these prestigious institutions reflects her dedication to clinical excellence in women’s reproductive health.

🧬 Research Focus and Academic Contributions

Dr. Ayyar has demonstrated a deep commitment to research and scientific advancement in reproductive medicine. Her research has been recognized through multiple awards, including the 2022 President’s Presenter’s Research Award by the Society for Reproductive Investigators, and the First Place Oral Presentation at Baylor's Resident Research Day. Her areas of research have included reproductive endocrinology, infertility, adolescent gynecology, and transplantation, with recognition such as the Poster of Distinction at the American Transplant Congress.

🏆 Honors, Awards, and Distinctions

Dr. Ayyar’s commitment to excellence is reflected in a long list of honors:

  • 🥇 2024 Society’s Research Grant Award – CLESOG

  • 🏅 2023 “Ova-Achiever” Teaching Award – Baylor College of Medicine

  • 🎓 2018 Junior AOA Inductee – Texas Tech University

  • 🧠 2016 AATS Summer Intern Scholar – American Association for Thoracic Surgery

  • 💼 Multiple REI Resident Divisional Awards – 2021, 2023

These accolades span academic, research, and teaching domains, underlining her balanced and exceptional performance.

📚 Editorial and Scholarly Activities

Dr. Ayyar has served as an Ad Hoc Reviewer for Faculty Opinions (2021–2022) and reviewed manuscripts for leading journals such as Fertility and Sterility and Journal of Pediatric and Adolescent Gynecology. Her review of “Morris RS, F S Rep 2021” was published in Faculty Opinions, showing her role in shaping the academic discourse in her field. She worked closely under the mentorship of Dr. Schutt, further refining her academic acumen.

💡 Technical and Research Skills

Dr. Ayyar possesses a diverse range of technical and clinical skills, especially in the areas of:

  • Assisted reproductive technologies (ART)

  • Female endocrine disorders

  • Clinical data analysis and presentation

  • Medical education techniques
    Her ability to merge clinical insights with data-driven research continues to inform her practice and mentorship efforts.

👩‍🏫 Teaching and Mentorship Excellence

A natural educator, Dr. Ayyar has received multiple teaching awards, such as the Distinguished Educator’s Award and the “Ova-Achiever” Teaching Award, both from Baylor College of Medicine in 2023. She actively mentors residents and medical students, integrating clinical practice with evidence-based education.

🌐 Professional Societies and Network

She holds active memberships in several prestigious medical societies:

  • 🔬 Alpha Omega Alpha (AOA) – Full Member (2018–present)

  • 🩺 American College of Obstetrics and Gynecology (ACOG) – Junior Fellow

  • 🧪 Society for Reproductive Investigation

  • 🧬 American Society of Reproductive Medicine

These memberships not only enhance her access to cutting-edge research but also reflect her active engagement in advancing reproductive healthcare.

🔍 Impact and Influence

Dr. Ayyar’s contributions have significantly impacted the fields of Obstetrics, Gynecology, and Reproductive Medicine. Her work has influenced both clinical practices and educational frameworks. Through her research presentations, clinical excellence, and peer-reviewed contributions, she continues to shape the future of women’s health.

🌟 Legacy and Future Contributions

As she continues her fellowship, Dr. Ayyar is poised to become a leader in reproductive medicine, integrating innovation, compassion, and academic excellence. Her long-term vision includes mentoring future physicians, advancing ART techniques, and shaping policy and practice standards in reproductive endocrinology.

Selected Publications

Authors: Archana Ayyar, Marian Khalil, Maggie Wong, Rebecca Chung, Kathryn Coyne, Joseph Findley, Rachel Weinerman, Rebecca Flyckt, Katelyn Perroz Sofaly, Sung Tae Kim
Journal: Reproductive Medicine
Year: 2025
Additional considerations for hysteroscopic morcellation versus electric vacuum aspiration
Authors: Archana Ayyar, Steven R. Lindheim, Rebecca Flyckt
Journal: Fertility and Sterility
Year: 2024
Novel intragraft regulatory lymphoid structures in kidney allograft tolerance
Authors: Ivy A. Rosales, Chao Yang, Evan A. Farkash, Tameem Ashry, Jifu Ge, Imad Aljabban, Archana Ayyar, Dorothy Ndishabandi, Rebecca White, Elena Gildner, et al.
Journal: American Journal of Transplantation
Year: 2022
Management of a Novel Autoimmune Disease, COPA Syndrome, in Pregnancy
Authors: Archana Ayyar, Rachel D. Seaman, Kalpalatha Guntupalli, Mary C. Tolcher, Daniel Martin
Journal: Case Reports in Obstetrics and Gynecology
Year: 2022

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Published on by Invention Awards

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

🎓 Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

🎓 Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

👨‍🏫 Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 – PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 – B.Pharm & PHT 417 – PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 – PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

🏢 Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

🏛️ Council & Committee Memberships

Pharmaceutics Department Council Member – (2017–Present)

Academic Committee Member – College of Pharmacy (2017–2018)

Annual Research Day Committee Member – (2017–2018)

🔬 Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

🏆 Awards & Recognitions

Distinction Award for Academic Excellence – Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award – University of Alberta (2014)

Graduate Students' Association Academic Travel Award – University of Alberta (2015, 2016)

CSPS Meeting Travel Award – Faculty of Pharmacy, University of Alberta (2015, 2016)

🎓 Licenses & Certifications

Licensed Pharmacist – Saudi Commission for Health Specialties (SCFHS) (2010–Present)

📜 Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.